Artificial Pancreas Device System Market is Growing at a CAGR of 20.9% till 2025 led by Bigfoot Biomedical, Medtronic, Dexcom, Admetsys, Beta Bionics, Cellnovo, Tandem Diabetes Care

Artificial pancreas device system are the devices that closely copy the glucose regulating function of fit pancreas. The device not only monitors the glucose levels in the body, it also automatically adjusts the distribution of insulin to reduce high blood glucose levels and lowers the incidence of low blood glucose with less or no input from the patient. According to the Food and Drug Administration, the use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment. The report would be of an interest to various stakeholders operating in the artificial pancreas device systems market. These stakeholders include artificial pancreas product manufacturers, vendors, and distributors, research institutes and government organizations, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions and others.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100001232

Major Players Operating in the Artificial Pancreas Device Systems Market-
1. Defymed
2. TypeZero Technologies, Inc.
3. Insulet Corporation
4. Bigfoot Biomedical, Inc.
5. Medtronic
6. Dexcom, Inc.
7. Admetsys
8. Beta Bionics
9. Cellnovo
10. Tandem Diabetes Care

According to a new market research study titled ‘Artificial Pancreas Device Systems Market to 2025 – Global Analysis and Forecasts by Type and Geography. The global artificial pancreas device systems market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2018-2025. The report highlights the trends prevalent in the global artificial pancreas device systems market and the factors driving the market along with those that act as deterrents to its growth.

The market is likely to witness a rapid growth owing to factors such as growing prevalence of diabetes, developments by major players, and rise in demand for computerized systems for glycemic control. Additionally, the market is also likely to be accelerated by new product launches by market players that are presently in the pipeline. However, availability of alternatives for artificial pancreas device systems and high cost associated with these systems are expected to hinder the market growth in the coming years.

Browse Complete Report at https://www.theinsightpartners.com/reports/artificial-pancreas-device-system-market

Major Market Developments-
• For instance, in February, 2018, Medtronic received the U.S. Food and Drug Administration (FDA) approval for new arm indication for the Guardian Sensor 3. The latest indication enables patients to wear the sensor on the upper arm, which delivers more flexible and enhanced performance for users, and improved accuracy to be used with the MiniMed 670G system.
• Additionally, in July, 2016, Tandem Diabetes Care and TypeZero Technologies entered into an agreement for the launch of TypeZero’s artificial pancreas (AP) tech and Tandem’s t:slim Insulin Pump. This agreement is an important step for bringing closed-loop artificial pancreas system to the diabetes community.

The report segments the global artificial pancreas device systems market as follows:

Global Artificial Pancreas Device Systems Market – By Type
• Control to Range
• Control to Target
• Threshold-Suspended Device Systems

Global Artificial Pancreas Device Systems Market – By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Asia Pacific (APAC)
• Japan
• China
• India
• Middle East & Africa (MEA)
• South Africa
• UAE
• Saudi Arabia
• South & Central America (SCAM)
• Brazil

Buy this Complete Report with TOC Access now at https://www.theinsightpartners.com/buy/TIPHE100001232

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.